Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06735027 · ClinicalTrials.gov registry record · NA
Corticosteroid Injection Versus Nerve Block
A NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06735027: Recruiting NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy, sponsored by University of Minnesota.
NCT06735027 is a NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06735027, a NA study of Glenohumeral Arthritis and Rotator Cuff Arthropathy, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.
Primary Outcome
a validated continuous scale assessment for pain
Conditions Studied
Interventions
- OTHER intraarticular corticosteroid injection (IACI)
- OTHER suprascapular nerve block (SSNB)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-02 |
| Est. Completion | 2027-01-02 |
| Phase | NA |
What NCT06735027 shows while recruiting
NCT06735027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Glenohumeral Arthritis appearing as the primary indexed condition, and to 2 interventions - of which intraarticular corticosteroid injection (IACI) is the first listed.
NCT06735027 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06735027 about?
NCT06735027 is a clinical study titled "Corticosteroid Injection Versus Nerve Block". The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular n...
What is the current status of trial NCT06735027?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-02. Estimated completion is 2027-01-02.
What conditions does trial NCT06735027 study?
This clinical trial studies the following conditions: Glenohumeral Arthritis, Rotator Cuff Arthropathy.
What interventions are being tested in trial NCT06735027?
The interventions under investigation include: intraarticular corticosteroid injection (IACI) (OTHER), suprascapular nerve block (SSNB) (OTHER).
Who is sponsoring clinical trial NCT06735027?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06735027 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glenohumeral Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06735027's enrollment target sits among peer trials
40 1448th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI